Background: People with type 2 diabetes are at a higher risk of debilitating consequences such as impaired vision, nephropathy, and decreased quality in life, resulting in premature death. The cost of diabetes care is also at least 3.2 times greater than the average per capita health care expenditure, rising to 9.4 times in the presence of complications. Review of Literature: Articles chosen from PubMed and CINAHL databases using key terms Type 2 diabetes mellitus, mobile applications, chronic care, the program of all-inclusive care for the elderly, diabetes management, quality improvement, and quality of life. Of the 214 articles, 10 met the criteria for review. Purpose: This paper aims to improve Type 2 Diabetes Mellitus (T2DM) for PACE participants by lowering their hemoglobin A1c to reduce their risk of morbidity and mortality while improving their quality of life using the Chronic Care Model. Methods: 30 Alcatel Joy Tablets supplied to PACE participants with a diagnosis of T2DM loaded with an application to provide education on the management of T2DM, 12 consented to participate in the practice change. Participants attended an educational session on device functionality and expectation of use. Data extraction of baseline A1Cs collected. Follow-up with participants will occur monthly, either by phone or when present in the office. Pre/post-survey responses will conclude at the end of the project in Dec 2022. Implementation Plan/Procedure: In September 2022, participants were provided the Alcatel Joy Tablets and began learning about T2DM and managing the disease by taking steps to lower their hemoglobin A1c. In December 2022, hemoglobin A1c data and pre/post-test survey results analysis consisted of calculations using a two-paired T-test to determine the success of project implementation and outcomes.
Read
